EX-10.4 8 dex104.htm FORM OF EXCLUSIVE PATENT LICENSE AGREEMENT EXCLUSIVE PATENT LICENSEExclusive Patent License • May 5th, 2020
THIS EXCLUSIVE PATENT LICENSE (hereinafter “EPL”) is effective as of , by and between NCR Corporation, a Maryland corporation, having a principal place of business at 1700 S. Patterson Blvd., Dayton, Ohio 45479 (hereinafter “NCR”), and Teradata US, Inc., a Delaware corporation, having a principal place of business at 1700 S. Patterson Blvd., Dayton, Ohio 45479 (hereinafter “Teradata”), each hereinafter referred to as a “Party.”
AGREEMENTExclusive Patent License • July 26th, 2000 • Rosetta Inpharmatics Inc • Services-commercial physical & biological research • Washington
EXCLUSIVE PATENT LICENSEExclusive Patent License • March 15th, 2011 • Imaging Diagnostic Systems Inc /Fl/ • Electromedical & electrotherapeutic apparatus
THIS LICENSE AGREEMENT made and entered into this 2nd day of June 1998 by and between Imaging Diagnostic Systems, Inc., a Florida Corporation "LICENSEE") and Richard Grable, an Individual ("GRABLE").
EXCLUSIVE PATENT LICENSE AGREEMENTExclusive Patent License • December 2nd, 2017
THE HYPERLINKED ANNOTATIONS IN THIS DOCUMENT ARE INTENDED TO HELP THE READER UNDERSTAND THE BASIS IN LAW OR UNIVERSITY POLICY FOR TERMS IN THE UNIVERSITY’S STANDARD EXCLUSIVE PATENT LICENSE AGREEMENT. THESE ANNOTATIONS ARE NOT INTENDED TO ALTER OR MODIFY THIS AGREEMENT. IF THERE IS ANY DISPUTE AS TO THE INTENT OR MEANING OF THE ANNOTATIONS VERSUS THE ACTUAL AGREEMENT, ONLY THE TEXT OF THE AGREEMENT IS INTENDED TO BE INTERPRETED
